It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objective: Candidemia is a life-threatening infection that causes high mortality rates in intensive care units (ICUs). This study aims to evaluate predictors of the outcome of patients with candidemia in ICU.
Patients and Methods: This observational, retrospective study included patients with Candida bloodstream infection (BSI) in ICUs between 6 years of the episode. A binary logistic regression analysis was conducted to inspect the association with mortality.
Results: The median age of 74 patients was 68.5, and 53.8% were men. C. parapsilosis was the most frequently isolated fungal species.
The 30-day mortality rate was 50%. In the logistic regression model the Acute Physiology and Chronic Health Evaluation (APACHE)
II score, positive blood culture on the seventh day, inotropes needed on the day of blood culture positivity, and ventilator-associated pneumonia (VAP) were significant risk factors for the outcome of patients. There was no difference in mortality between an early start of antifungal treatment or central venous catheter removal time.
Conclusion: A shift to C. parapsilosis is observed in this study. Host-related factors such as APACHE II score, need for mechanical ventilation or need for inotropes affect mortality more than early treatment and source control in patients with Candida BSI.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer